Back

Ectopic engraftment of nociceptive neurons derived from hPSCs for pain relief and joint homeostasis

Dong, X.; Lee, G.; Wang, Z. P.; Zhang, W.; Cao, X.; Peng, J.; Wang, J.; Wu, Z.

2025-12-19 neuroscience
10.64898/2025.12.16.694733 bioRxiv
Show abstract

Chronic pain arises from the interplay of inflammatory signals that activate and sensitize nociceptors within injured tissues. Most analgesics fail clinically due to their mono-targeted mechanisms. Here, we apply human pluripotent stem cell-derived nociceptive neurons (hPSC-NNs) as therapeutic agents for osteoarthritis, targeting both pain and joint degeneration. We generated sensory neurons from hPSCs and identified CD200 as a nociceptor marker. Transcriptomic and functional profiling revealed that CD200highhPSC-NNs closely resemble human nociceptors, expressing pain-relevant receptors and ion channels. Strikingly, ectopic transplantation of CD200highhPSC-NNs into the knee joint of osteoarthritic mice reduced pain and promoted bone and cartilage repair, whereas CD200low cells exhibited no benefit. Mechanistically, human and mouse proteomics suggest that CD200highhPSC-NNs act as decoys by sequestering inflammatory ligands while secreting reparative factors in joint tissues. These findings uncover a fundamental role of nociceptors in tissue repair, providing a multi-targeted, disease-modifying strategy for OA and chronic pain. GRAPHIC ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/694733v1_ufig1.gif" ALT="Figure 1"> View larger version (70K): org.highwire.dtl.DTLVardef@15f0948org.highwire.dtl.DTLVardef@5a59bforg.highwire.dtl.DTLVardef@1ba4439org.highwire.dtl.DTLVardef@1d518d1_HPS_FORMAT_FIGEXP M_FIG C_FIG HIGHLIGHTSO_LIhPSC-derived nociceptors (hPSC-NNs) as Decoy Engraftment for Cellular Interception and Repair (DECIR) when transplanted into the knee joint, extending beyond conventional regenerative strategies C_LIO_LICD200 serves as a clinically actionable surface marker for the purification of hPSC-NNs C_LIO_LIEctopic grafting of CD200high hPSC-NNs delivers dual benefits, alleviating pain and modulating the neuro-immune environment within joint tissues C_LIO_LIProteomic analyses reveal that CD200highhPSC-NNs sequester inflammatory mediators and secrete reparative factors to support joint homeostasis C_LI

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Cell Stem Cell
57 papers in training set
Top 0.1%
28.2%
2
Cell
370 papers in training set
Top 0.8%
10.3%
3
Nature Communications
4913 papers in training set
Top 28%
6.5%
4
Nature
575 papers in training set
Top 5%
4.9%
5
Nature Biotechnology
147 papers in training set
Top 2%
4.3%
50% of probability mass above
6
Cell Reports
1338 papers in training set
Top 14%
3.7%
7
Advanced Science
249 papers in training set
Top 6%
3.3%
8
Science Advances
1098 papers in training set
Top 8%
3.1%
9
Nature Immunology
71 papers in training set
Top 0.7%
3.1%
10
Nature Neuroscience
216 papers in training set
Top 4%
1.7%
11
eLife
5422 papers in training set
Top 41%
1.7%
12
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 31%
1.7%
13
Nature Biomedical Engineering
42 papers in training set
Top 0.9%
1.5%
14
Nature Methods
336 papers in training set
Top 5%
1.4%
15
Developmental Cell
168 papers in training set
Top 9%
1.4%
16
Science Translational Medicine
111 papers in training set
Top 3%
1.4%
17
Nature Materials
21 papers in training set
Top 0.6%
1.4%
18
Science
429 papers in training set
Top 16%
1.4%
19
Cell Reports Methods
141 papers in training set
Top 3%
1.4%
20
JCI Insight
241 papers in training set
Top 6%
0.9%
21
EMBO Molecular Medicine
85 papers in training set
Top 3%
0.9%
22
Cell Reports Medicine
140 papers in training set
Top 6%
0.9%
23
iScience
1063 papers in training set
Top 31%
0.8%
24
npj Regenerative Medicine
21 papers in training set
Top 0.3%
0.8%
25
Neuron
282 papers in training set
Top 8%
0.8%
26
Journal of Clinical Investigation
164 papers in training set
Top 6%
0.8%
27
Nucleic Acids Research
1128 papers in training set
Top 18%
0.7%
28
Nature Medicine
117 papers in training set
Top 5%
0.7%
29
Molecular Therapy
71 papers in training set
Top 3%
0.7%
30
Brain, Behavior, and Immunity
105 papers in training set
Top 3%
0.5%